Avondale Securities Upgrades Abaxis (ABAX) to Market Outperform
Avondale Securities upgrades Abaxis (Nasdaq: ABAX) from Market Perform to Market Outperform. PT $27. To see all the upgrades/downgrades on shares of ABAX, visit our Analyst Ratings page. Abaxis, Inc. (Abaxis) develops, manufactures, markets and sells portable blood analysis systems for use in any human or veterinary patient-care setting to provide...
Get Alerted When News Hits On This Stock - FREE!